V-32R

N/A

Report date: 2025/06/11 10:58:27
NME

Base Information

Drug NameV-32R
Drug Alias NameTRV-32-RV-32R
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic RetinopathyGlaucoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTeraclon IDF SL
China Registration ClassN/A

Develop Information

Active CompaniesTeraclon IDF SL
Inactive CompaniesN/A
Active IndicationsDiabetic RetinopathyGlaucoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A